DnB Asset Management
IRON icon

DnB Asset Management’s Disc Medicine IRON Stock Holding History

DnB Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.35M Sell
73,127
-23,628
-24% -$1.62M 0.02% 471
2026
Q1 		$6.19M Buy
96,755
+12,500
+15% +$867K 0.02% 390
2025
Q4 		$6.69M Buy
84,255
+78,733
+1,426% +$6.65M 0.02% 376
2025
Q3 		$365K Buy
5,522
+939
+20% +$55.9K ﹤0.01% 684
2025
Q2 		$243K Buy
+4,583
New +$215K ﹤0.01% 682

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

DnB Asset Management's IRON Position: Q2 2026 in Review

DnB Asset Management reduced its Disc Medicine (IRON) stake by 24% in Q2 2026, selling an estimated $1.62M and leaving 73,127 shares worth $5.35M. The position accounts for 0.02% of the portfolio, ranked #471.

DnB Asset Management first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.69M in Q4 2025. 76 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • DnB Asset Management held 73,127 shares of Disc Medicine worth $5.35M as of Q2 2026.
  • DnB Asset Management sold 23,628 Disc Medicine shares in Q2 2026, an estimated $1.62M.
  • Disc Medicine made up 0.02% of DnB Asset Management's portfolio in Q2 2026, its #471 holding.
  • DnB Asset Management first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
  • DnB Asset Management's Disc Medicine position peaked at $6.69M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.